Literature DB >> 7039889

A study of C3b deposition on yeast surfaces by sera of known opsonic potential.

M W Turner, J F Mowbray, D R Roberton.   

Abstract

C3c fragments released by the actin of trypsin from C3b molecules bound to zymosan may be readily quantitated by conventional gel techniques to give a measurement of the efficiency of C3b opsonization. Using this approach, the rate of deposition of C3b molecules was found to be very rapid in sera known to opsonize yeast normally. In contrast, sera defective in yeast opsonization deposited C3b much more slowly. The C3b elution technique was found to correlate well with both a direct phagocytosis assay using baker's yeast (r = 0.87, P less than 0.001) and a recently described neutrophil iodide uptake assay (r = 0.88, P less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7039889      PMCID: PMC1536409     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  A rapid objective method for measuring the yeast opsonisation activity of serum.

Authors:  R J Levinsky; B A Harvey; S Paleja
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

3.  A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.

Authors:  M Yamamura; H Valdimarsson
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

4.  A defect of the alternative pathway of complement.

Authors:  J F Soothill; B A Harvey
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

5.  Defective yeast opsonization and C2 deficiency in atopic patients.

Authors:  M W Turner; J F Mowbray; B A Harvey; J Brostoff; R S Wells; J F Soothill
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

6.  Iodination by human polymorphonuclear leukocytes: a re-evaluation.

Authors:  S J Klebanoff; R A Clark
Journal:  J Lab Clin Med       Date:  1977-03

7.  Defective opsonization. A common immunity deficiency.

Authors:  J F Soothill; B A Harvey
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

8.  Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.

Authors:  J R Carlo; S Ruddy; E J Studer; D H Conrad
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

9.  Studies of the molecular mechanisms of C3b inactivation and a simplified assay of beta 1H and the C3b inactivator (C3bINA).

Authors:  T A Gaither; C H Hammer; M M Frank
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

10.  The role of membrane receptors for C3b and C3d in phagocytosis.

Authors:  A G Ehlenberger; V Nussenzweig
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more
  11 in total

1.  Deficiency of mannan binding protein--a new complement deficiency syndrome.

Authors:  M W Turner
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations.

Authors:  M Super; R J Levinsky; M W Turner
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

3.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

4.  The role of opsonins in vacuolar sealing and the ingestion of zymosan by human neutrophils.

Authors:  A S Kemp; M W Turner
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

5.  Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.

Authors:  M W Turner; C Grant; N D Seymour; B Harvey; R J Levinsky
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

6.  Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults.

Authors:  J Aittoniemi; H Soranummi; A T Rovio; M Hurme; T Pessi; M Nieminen; J Karjalainen
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

7.  A common congenital immunodeficiency predisposing to infection and atopy in infancy.

Authors:  V F Richardson; V F Larcher; J F Price
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

Review 8.  Mammalian lectins in activation and clearance mechanisms involving the complement system.

Authors:  K B Reid; M W Turner
Journal:  Springer Semin Immunopathol       Date:  1994

9.  The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response.

Authors:  S Thiel; U Holmskov; L Hviid; S B Laursen; J C Jensenius
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

Review 10.  Mannose-binding lectin in innate immunity: past, present and future.

Authors:  R M Dommett; N Klein; M W Turner
Journal:  Tissue Antigens       Date:  2006-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.